Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
NASDAQ:DXCM
Price:
127.2 USD
-0.15%
Market Closed
Updated:
May 1, 2024
P/S
Price to Sales
Price to Sales
13.5
Current
15.2
Median
2.4
Industry
Lower
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=13.5
Market Cap
/
49B
Revenue
3.6B
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49B USD | 13.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
185B USD | 4.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.2B USD | 18.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.9B USD | 6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108B USD | 3.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 3.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 2.7 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.7B USD | 8.4 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
38.9B USD | 10.6 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
11.1
2-Years Forward
P/S
9.3
3-Years Forward
P/S
7.9
You don't have any saved screeners yet
